Next Article in Journal
Manufacturing Bacteriophages (Part 1 of 2): Cell Line Development, Upstream, and Downstream Considerations
Next Article in Special Issue
A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2)
Previous Article in Journal
Engineering Mitochondriotropic Carbon Dots for Targeting Cancer Cells
Previous Article in Special Issue
Correction: Zanella et al. Tenofovir, Another Inexpensive, Well Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection. Pharmaceuticals 2021, 14, 454
 
 
Review

Article Versions Notes

Pharmaceuticals 2021, 14(9), 933; https://doi.org/10.3390/ph14090933
Action Date Notes Link
article xml file uploaded 17 September 2021 09:44 CEST Original file -
article xml uploaded. 17 September 2021 09:44 CEST Update -
article pdf uploaded. 17 September 2021 09:44 CEST Version of Record https://www.mdpi.com/1424-8247/14/9/933/pdf-vor
article html file updated 17 September 2021 09:45 CEST Original file -
article xml file uploaded 23 September 2021 03:57 CEST Update -
article xml uploaded. 23 September 2021 03:57 CEST Update -
article pdf uploaded. 23 September 2021 03:57 CEST Updated version of record https://www.mdpi.com/1424-8247/14/9/933/pdf-vor
article html file updated 23 September 2021 03:58 CEST Update -
article xml file uploaded 24 September 2021 08:48 CEST Update -
article xml uploaded. 24 September 2021 08:48 CEST Update https://www.mdpi.com/1424-8247/14/9/933/xml
article pdf uploaded. 24 September 2021 08:48 CEST Updated version of record https://www.mdpi.com/1424-8247/14/9/933/pdf
article html file updated 24 September 2021 08:50 CEST Update -
article html file updated 30 July 2022 06:15 CEST Update https://www.mdpi.com/1424-8247/14/9/933/html
Back to TopTop